Gold and Silver Prices Fluctuate as Middle East Tensions and Strong Dollar Drive Uncertainty
Trump Pressures Bank of America JPMorgan Over Alleged Conservative Discrimination
L3Harris Technologies Stock Wall Street Weighs Bullish Defense Outlook Against Valuation Concerns
BTS Secures Top American Music Awards Honor for Second Consecutive Year
Healthcare and Tech Lead SP 500 to Modest Gains Communication Services Lags
Silicon Valley Turns to Mundane Businesses AI and Dealmaking Reshape Accounting Property Management
OMAB Q1 2026 Earnings EPS Misses Estimates Shares Decline
Horizon Bancorp Inc HBNC Q1 2026 Earnings EPS Beats Estimates Despite Modest Share Declines
Enel Chile Q4 2025 Earnings EPS Beats Estimates by 281 Amidst Operational Resilience
BTCS Q1 2026 Earnings EPS Misses Estimates as DevelopmentStage Company Faces Headwinds
Ulta Beauty Q1 2026 Earnings EPS Misses Estimates Amid Challenging Beauty Retail Environment
MU Q1 2026 Earnings Strong EPS Beat Driven by AI Memory Demand Stock Falls 146
GoHealth Inc GOCO Surges 744 as Buyers Defend Key Support Near 066
Udemy Inc UDMY Stabilizes Near Support as Market Awaits Catalyst
BRC Inc BRCC Declines 257 as Shares Approach Key Support Level
Helmerich Payne HP Posts Modest Gain Key Levels in Focus
Pilgrims Pride PPC Edges Lower Amid Sector Pressure Holding Above Key Support
Chunghwa Telecom Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower
Standex International SXI Q1 2026 Earnings EPS Misses Estimates but Shares Edge Higher
ABCL Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction
POET Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage
Brookfield Asset Management Inc BAM Q1 2026 Earnings Slight EPS Miss Amid Stable Operations
AirJoule Technologies Q1 2026 Earnings Significant EPS Miss Amid Development Stage Stock Rises on Strategic Hopes
Professional Title AIDriven Hiring Doom Loop JobSeekers and Recruiters in an Arms Race of Homogenized Applications
Pegasystems Q1 2026 Earnings EPS Misses Estimates as Profitability Pressures Emerge
Propanc Biopharma PPCB Slides 69 as Weak Momentum Tests Key Support